179 related articles for article (PubMed ID: 26981333)
1. A Drug Delivery System for Administration of Anti-TNF-α Antibody.
Robert MC; Frenette M; Zhou C; Yan Y; Chodosh J; Jakobiec FA; Stagner AM; Vavvas D; Dohlman CH; Paschalis EI
Transl Vis Sci Technol; 2016 Mar; 5(2):11. PubMed ID: 26981333
[TBL] [Abstract][Full Text] [Related]
2. Sustained Subconjunctival Delivery of Infliximab Protects the Cornea and Retina Following Alkali Burn to the Eye.
Zhou C; Robert MC; Kapoulea V; Lei F; Stagner AM; Jakobiec FA; Dohlman CH; Paschalis EI
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):96-105. PubMed ID: 28114570
[TBL] [Abstract][Full Text] [Related]
3. Sustained Inhibition of VEGF and TNF-α Achieves Multi-Ocular Protection and Prevents Formation of Blood Vessels after Severe Ocular Trauma.
Zhou C; Lei F; Sharma J; Hui PC; Wolkow N; Dohlman CH; Vavvas DG; Chodosh J; Paschalis EI
Pharmaceutics; 2023 Jul; 15(8):. PubMed ID: 37631272
[TBL] [Abstract][Full Text] [Related]
4. Microporous Drug Delivery System for Sustained Anti-VEGF Delivery to the Eye.
Zhou C; Singh A; Qian G; Wolkow N; Dohlman CH; Vavvas DG; Chodosh J; Paschalis EI
Transl Vis Sci Technol; 2020 Jul; 9(8):5. PubMed ID: 32855852
[TBL] [Abstract][Full Text] [Related]
5. Biodegradable Microsphere-Hydrogel Ocular Drug Delivery System for Controlled and Extended Release of Bioactive Aflibercept In Vitro.
Liu W; Lee BS; Mieler WF; Kang-Mieler JJ
Curr Eye Res; 2019 Mar; 44(3):264-274. PubMed ID: 30295090
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Biodegradable Microsphere-Hydrogel Ocular Drug Delivery System for Controlled and Extended Release of Ranibizumab.
Liu W; Borrell MA; Venerus DC; Mieler WF; Kang-Mieler JJ
Transl Vis Sci Technol; 2019 Jan; 8(1):12. PubMed ID: 30701127
[TBL] [Abstract][Full Text] [Related]
7. Biodegradable Microspheres and Hydrogel Drug Delivery System of Tumor Necrosis Factor (TNF) Inhibitor and Growth Differentiation Factor 5 (GDF5) Reduces Disk Inflammation in the Rabbit Model.
Yuan B; Rudeen K; Li J; Williams B; Sumughan S; Lopez G; An HS; Kang-Mieler JJ; Chee AV
Spine (Phila Pa 1976); 2023 Aug; 48(15):E257-E265. PubMed ID: 37075330
[TBL] [Abstract][Full Text] [Related]
8. Neutralization of ocular surface TNF-α reduces ocular surface and lacrimal gland inflammation induced by in vivo dry eye.
Ji YW; Byun YJ; Choi W; Jeong E; Kim JS; Noh H; Kim ES; Song YJ; Park SK; Lee HK
Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7557-66. PubMed ID: 24052636
[TBL] [Abstract][Full Text] [Related]
9. Anti-tumor necrosis factor-alpha-loaded microspheres as a prospective novel treatment for Crohn's disease fistulae.
Foong KS; Patel R; Forbes A; Day RM
Tissue Eng Part C Methods; 2010 Oct; 16(5):855-64. PubMed ID: 19886803
[TBL] [Abstract][Full Text] [Related]
10. Planning Implications Related to Sterilization-Sensitive Science Investigations Associated with Mars Sample Return (MSR).
Velbel MA; Cockell CS; Glavin DP; Marty B; Regberg AB; Smith AL; Tosca NJ; Wadhwa M; Kminek G; Meyer MA; Beaty DW; Carrier BL; Haltigin T; Hays LE; Agee CB; Busemann H; Cavalazzi B; Debaille V; Grady MM; Hauber E; Hutzler A; McCubbin FM; Pratt LM; Smith CL; Summons RE; Swindle TD; Tait KT; Udry A; Usui T; Westall F; Zorzano MP
Astrobiology; 2022 Jun; 22(S1):S112-S164. PubMed ID: 34904892
[TBL] [Abstract][Full Text] [Related]
11. A self-assembling peptide hydrogel-based drug co-delivery platform to improve tissue repair after ischemia-reperfusion injury.
Liu S; Zhao M; Zhou Y; Li L; Wang C; Yuan Y; Li L; Liao G; Bresette W; Chen Y; Cheng J; Lu Y; Liu J
Acta Biomater; 2020 Feb; 103():102-114. PubMed ID: 31843715
[TBL] [Abstract][Full Text] [Related]
12. In Vivo Efficacy of an Injectable Microsphere-Hydrogel Ocular Drug Delivery System.
Osswald CR; Guthrie MJ; Avila A; Valio JA; Mieler WF; Kang-Mieler JJ
Curr Eye Res; 2017 Sep; 42(9):1293-1301. PubMed ID: 28557571
[TBL] [Abstract][Full Text] [Related]
13. Treatment Efficacy and Biocompatibility of a Biodegradable Aflibercept-Loaded Microsphere-Hydrogel Drug Delivery System.
Liu W; Tawakol AP; Rudeen KM; Mieler WF; Kang-Mieler JJ
Transl Vis Sci Technol; 2020 Oct; 9(11):13. PubMed ID: 33117605
[TBL] [Abstract][Full Text] [Related]
14. Erratum: Eyestalk Ablation to Increase Ovarian Maturation in Mud Crabs.
J Vis Exp; 2023 May; (195):. PubMed ID: 37235796
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous Release of Aflibercept and Dexamethasone from an Ocular Drug Delivery System.
Rudeen KM; Liu W; Mieler WF; Kang-Mieler JJ
Curr Eye Res; 2022 Jul; 47(7):1034-1042. PubMed ID: 35343355
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic intradermal delivery of tumor necrosis factor-alpha antibodies using tip-loaded dissolvable microneedle arrays.
Korkmaz E; Friedrich EE; Ramadan MH; Erdos G; Mathers AR; Burak Ozdoganlar O; Washburn NR; Falo LD
Acta Biomater; 2015 Sep; 24():96-105. PubMed ID: 26093066
[TBL] [Abstract][Full Text] [Related]
17. A double-crosslinked nanocellulose-reinforced dexamethasone-loaded collagen hydrogel for corneal application and sustained anti-inflammatory activity.
Xeroudaki M; Rafat M; Moustardas P; Mukwaya A; Tabe S; Bellisario M; Peebo B; Lagali N
Acta Biomater; 2023 Dec; 172():234-248. PubMed ID: 37866722
[TBL] [Abstract][Full Text] [Related]
18. Compartmental and COMSOL Multiphysics 3D Modeling of Drug Diffusion to the Vitreous Following the Administration of a Sustained-Release Drug Delivery System.
Dosmar E; Vuotto G; Su X; Roberts E; Lannoy A; Bailey GJ; Mieler WF; Kang-Mieler JJ
Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834276
[TBL] [Abstract][Full Text] [Related]
19. Ocular Pharmacokinetics of Brimonidine Drug Delivery System in Monkeys and Translational Modeling for Selection of Dose and Frequency in Clinical Trials.
Tamhane M; Luu KT; Attar M
J Pharmacol Exp Ther; 2021 Sep; 378(3):207-214. PubMed ID: 34210753
[TBL] [Abstract][Full Text] [Related]
20. Alkali burn to the eye: protection using TNF-α inhibition.
Cade F; Paschalis EI; Regatieri CV; Vavvas DG; Dana R; Dohlman CH
Cornea; 2014 Apr; 33(4):382-9. PubMed ID: 24488127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
